(Q37237661)

19 August 2017

Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer (English)

1 reference

19 August 2017

0 references

10

Fadlo R Khuri

1 reference

19 August 2017

Taofeek K Owonikoko

1

1 reference

19 August 2017

Mohammad S Hossain

2

1 reference

19 August 2017

Chandar Bhimani

3

1 reference

19 August 2017

Zhengjia Chen

4

1 reference

19 August 2017

Sungjin Kim

5

1 reference

19 August 2017

Suresh S Ramalingam

6

1 reference

19 August 2017

Shi-Yong Sun

7

1 reference

19 August 2017

Dong M Shin

8

1 reference

19 August 2017

Edmund K Waller

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

22 January 2013

1 reference

19 August 2017

1 reference

19 August 2017

119

1 reference

19 August 2017

8

1 reference

19 August 2017

1503-1511

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

19 August 2017

1 reference

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Circulating levels of leptin, adiposity and breast cancer risk

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Exploiting death receptor signaling pathways for tumor therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Death receptor ligands, in particular TRAIL, to overcome drug resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

CD95's deadly mission in the immune system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Serum soluble fas level as a prognostic factor in patients with gynecological malignancies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Signaling defects in T lymphocytes of patients with malignancy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Prognostic impact of thyroid lymphocytic infiltration in patients with medullary thyroid carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Leptin levels in thyroid cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Prognostic significance of soluble Fas in the serum of patients with bladder cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Levels of soluble Fas ligand in myocarditis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3799834

Significance of serum soluble Fas ligand in patients with bladder carcinoma

3 September 2018

1 reference

12 December 2020

Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion

1 reference

12 December 2020

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

12 December 2020

Circulating soluble Fas concentration in breast cancer patients

1 reference

12 December 2020

Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers

1 reference

12 December 2020

Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes

1 reference

12 December 2020

Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma

1 reference

12 December 2020

Serum leptin: a marker of prostate cancer irrespective of obesity

1 reference

12 December 2020

Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer

1 reference

12 December 2020

TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention

1 reference

12 December 2020

Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults

1 reference

12 December 2020

[Increased serum soluble Fas ligand in hyperthyroid Graves' disease]

1 reference

12 December 2020

Management and outcome of recurrent well-differentiated thyroid carcinoma

1 reference

12 December 2020

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

1 reference

12 December 2020

Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?

1 reference

12 December 2020

Application of prognostic scoring systems in differentiated thyroid carcinoma

1 reference

12 December 2020

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27937

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23340930

1 reference